What this means
This study aims to find clues that mark when Alzheimer disease moves from no symptoms to having symptoms. It is still recruiting people, so no results have been reported yet.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 18 and over
- Where
- 1 site, including Missouri
The science
- Registered title
- Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)
- Trial ID
- NCT04579120 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- Alzheimer Disease
- What is tested
- [11C]-Pittsburgh Compound B ([11C]PiB), F 18 AV-1451 (Flortaucipir)
- Sponsor
- Tammie L. S. Benzinger, MD, PhD
- Ages
- 18 Years to no maximum
- Dates
- First posted Oct 8, 2020 · updated Jun 8, 2026
Registry summary
To identify factors that signal the transition from asymptomatic (preclinical) to symptomatic Alzheimer disease (AD).
Sites (1)
- Washington University School of Medicine, St Louis, Missouri, United States